Navigation Links
Study Results Reveal Oral Growth Hormone Boosting Supplement May Be Capable of Producing the Same Benefits as Synthetic Growth Hormone Injections
Date:11/21/2013

naturally and without the risks associated with injections."

And now SeroVital is making news again with the release of a study analyzing its effects on endurance. The results of this study showed that after two weeks of daily supplementation with this patented hGH secretagogue, not only was subjects' VO2max (the established measure of endurance) significantly increased, but numeric increases in both resting metabolic rate and estimated daily calorie expenditure were also seen.

"Increased measures of endurance are a well-established outcome of synthetic recombinant human growth hormone (rhGH) injections in adults," explains Dr. Heaton. "But our research on the SeroVital compound is so exciting because it's the first study of its kind to show that an oral growth hormone secretagogue may be capable of producing an expected benefit the same as that of synthetic hGH injections. And while the present study was not sufficiently powered to detect a significant change in mean resting metabolic rate and estimated daily calorie expenditure, these parameters showed increased values over baseline following the treatment period, evidencing the potential of the supplement to impart long-term fat burning effects."

The promise this research holds — especially because it doesn't require the administration of controversial synthetic hGH injections — could lead to an increased understanding of the ability of youthful growth hormone levels to impact excess body weight and fat mass, which is quickly becoming a major global health hazard. Dr. Heaton adds, "Further research in this area may provide insight to potential effects on body composition and weight regulation by the amino acid based hGH secretagogue. A larger multi-center study is being planned."

For more information about Obesity Week, visit www.ObesityWeek.com. To get the full details on SeroVital, visit

SOURCE SeroVital
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Irvine Center for Clinical Research Announces Open Enrollment for New Low Testosterone Study
2. Chicago Man Breathes Again Thanks to Northwestern Medicine Study
3. Phase IIb Study of Vanoxerine Shows Strong Safety and Statistically Significant Efficacy Signals for Treatment of Atrial Fibrillation
4. Zafgen Announces New Weight Loss and Safety Data from Phase 2 Study of Beloranib in Obesity at Obesity Week 2013
5. Epizymes EPZ-5676 DOT1L Inhibitor Demonstrates Encouraging Initial Findings in an Ongoing Phase 1 Dose Escalation Study
6. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions OVA1 Test in Presurgical Detection of Early-Stage Ovarian Cancer
7. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions Ovarian Cancer Test, OVA1
8. ChanRx to Present Results of Phase IIb Study in Atrial Fibrillation at the 2013 American Heart Association Scientific Sessions
9. Isis Pharmaceuticals Earns $1.5M from the Advancement of the Phase 2 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy
10. Certifications, Presentation of Study Results and Earnings Releases - Research Report on Agilent, Mindray, Bard, Tornier, and Life Technologies
11. Revalesio Initiates Phase IIa Study of RNS60 in Multiple Sclerosis at University Hospital Zurich
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014  According to the American Optometric ... spend on digital devices. An AOA survey reports that ... and 17 estimate they use an electronic device for ... AOA survey of parents revealed that only 40 percent ... for that same amount of time. Eye doctors are ...
(Date:7/22/2014)... July 22, 2014  Vernalis plc (LSE: VER) and Tris ... (POC) for CCP-08, the third programme to achieve ... collaboration. Under this collaboration, POC requires the successful ... pilot comparative study against an immediate release reference ... will make a milestone payment to Tris. ...
(Date:7/22/2014)... , July 22, 2014 /PRNewswire/ ... für umfassenden Schutz von Pharmazeuten und ...    Equashield ( http://www.equashield.com ... (Closed System Transfer Devices, CSTDs) für gefährliche Medikamente, ... Vertriebshändler und Hersteller von medizinischen Produkten, zu ...
Breaking Medicine Technology:Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 2Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 3Equashield ernennt Medikus zu seinem exklusiven österreichischen Vertriebspartner für seine geschlossenen Arzneimitteltransfersysteme 2
... PARK, Calif., Sept. 14 Praxis EMR has submitted its ... EMRs to apply for HITECH certification in the country. Under ... in federal incentives if they can demonstrate "meaningful use" of ... the U.S. Department of Health and Human Services to test ...
... Reportlinker.com announces that a new market research ... Autistic Disorder - Pipeline Assessment and Market ... Autistic Disorder - Pipeline ... SummaryGlobalData, the industry analysis specialist, has released ...
Cached Medicine Technology:Praxis EMR Among First to Apply for HITECH Certification 2Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017 3
(Date:7/23/2014)... July 23, 2014 PartnerTech Inc. ... in Lawrenceville, Georgia, welcomed Andreas von Uexkull to their ... of the U.S. von Uexkull, a top trade official ... tour of the U.S. to bring awareness and insight ... and Investment Partnership (TTIP). , As an expert ...
(Date:7/23/2014)... Picnic Lunches, Residents of The Clare can now enjoy the ... still dining on the fabulous cuisine of Chef Hagop Hagopian. ... to the beach or museum and we love to make ... said Brian Hughes, director of dining services for The Clare. ... , Hagopian, the executive chef of The Clare is trained ...
(Date:7/22/2014)... 22, 2014 Men and women who ... a portion of their disposable income each year on ... promoting its best anti aging products guide to help ... products guide is now released and accessible from any ... Known retailers were selected and inserted into the guide ...
(Date:7/22/2014)... Recently, iFitDress.com, a popular supplier of wedding dresses and special ... white party dresses to its product category. Additionally, ... available on its website. As a special offer, all customers ... get a discounted rate, up to 54% off. , A ... so its marketing specialist believes the new white party dresses ...
(Date:7/22/2014)... 23, 2014 Marietta, Georgia and surrounding areas ... In an efforts to lower population of needy pets; ... the Tigg Neuter Project have joined forces. Local businesses ... All proceeds will be presented to the Tigg Neuter Project. ... clinic family are excited to attend and host the event. ...
Breaking Medicine News(10 mins):Health News:Swedish Official Tours PartnerTech’s U.S. Facility 2Health News:Swedish Official Tours PartnerTech’s U.S. Facility 3Health News:Chicago’s The Clare Retirement Community Announces New Summertime Culinary Programs 2Health News:Best Anti Aging Products Guide Launched for Natural Product Buyers Online at News Portal 2Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2Health News:Marietta Vet Clinic Hosts 2014 Dog Days of Summer Pet Rescue Event 2
... safe and well-tolerated for elderly patients with chronic lymphocytic ... their disease, researchers from The University of Texas M. ... annual meeting of the American Society of Hematology. , ... of activity against CLL in our phase II clinical ...
... Deaconess Hospital has entered an agreement with Omaha-based ... Medicare-eligible patients access to an expanded lineup of Medicare ... Patients who elect coverage through Deaconess can now ... including Mutual of Omaha, UnitedHealthcare, Coventry, CIGNA, Aetna, Pyramid ...
... to Start Exploring Their Shared Genetics , ... Mountain View, CA (PRWEB) ... personal genetics, today announced it is offering a Multiple Kit discount ... in a single order will save $200 on the first three kits ...
... The end of fall marks an exciting time,for ... their,professional careers. Fellows from around the world will gather ... Interventions (SCAI),Third Annual Interventional Cardiology Fall Fellows Course in ... Given the aging population and the increasing number ...
... to blame; experts cite risk of skin cancer , , ... states to restrict and limit indoor tanning by children ... a worrisome trend, because ultraviolet radiation, whether from the ... skin cancer, the most common malignancy in the United ...
... Pharmaceuticals, Inc.,(Nasdaq: ARNA ) announced today ... lorcaserin, its novel drug candidate for the treatment ... Obesity, the official peer reviewed journal,of The Obesity ... with lorcaserin, as compared to placebo, experienced,statistically significant ...
Cached Medicine News:Health News:Lenalidomide safe as single therapy for elderly CLL patients 2Health News:Deaconess Hospital Partners With Senior Market Sales to Expand Insurance Offering for Medicare-Eligible Patients 2Health News:23andMe Announces Holiday Season Multi-Pack Discount 2Health News:23andMe Announces Holiday Season Multi-Pack Discount 3Health News:SCAI's Annual Fall Fellows Course Prepares New Interventional Cardiologists to Work in the Field 2Health News:SCAI's Annual Fall Fellows Course Prepares New Interventional Cardiologists to Work in the Field 3Health News:Laws Governing Indoor Tanning by Teens Don't Work 2Health News:Laws Governing Indoor Tanning by Teens Don't Work 3Health News:Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 2Health News:Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 3Health News:Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 4Health News:Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 5
... the typical patient, right for the not-so-typical ... you have the ability to address the ... least expect themeven after implant. St. Jude ... to be prepared in almost any situation, ...
... The R4Mplus offers global companies a ... meet RFID compliance initiatives. With die-cast ... variety of connectivity options, and complex ... a super value. Plus, the fully ...
... combines enhanced memory, processing capacity, ... reliable all-metal construction. Proven platform ... print speed make it the ... value reliability, productivity, consistent print ...
... companies a cost-effective and dependable performer ... With die-cast metal construction, centralized printer/encoder ... and complex multi-language font support, the ... the fully integrated RFID reader/encoder supports ...
Medicine Products: